NeoCG (ECG technology from WSU)

NeoCG is an improved screening/diagnostic tool for cardiovascular illnesses. Currently the ECG is the sole primary screening/diagnostic tool. The NeoCG delivers an increase in the precision of diagnosis enabling a reductions in the number of hospitalisations and a reduction in fatalities due to limited cardiac diagnoses. The current Electrocardiography market is worth more that US$1.5Bn p.a., with maintenance contracts of around the same value. Two major Australian hospitals have invited clinical trials of NeoCG.

Recent Posts
Search By Tags

1 Tonsley Blvd, Tonsley, Adelaide, Australia |Email: |Phone: +61 448 053 024

Copyright Innovyz 2018. All rights reserved | Press Notes | Website Terms of Use | ACN: 148 989 360 | We respect your privacy. Please review our Privacy Policy for more information.